Jul 05, 2016 06:13 am UTC| Business
OSAKA, Japan and LEUVEN, Belgium, July 5, 2016 -- Takeda Pharmaceutical Company Limited (TSE: 4502) ("Takeda") and TiGenix NV (Euronext Brussels: TIG) ("TiGenix") today announced that the companies have entered into an...
TiGenix reconfirms its strategic focus on its allogeneic stem cell platforms
Jul 05, 2016 06:09 am UTC| Business
LEUVEN, Belgium, July 5, 2016 -- TiGenix NV (Euronext Brussels: TIG), an advanced biopharmaceutical company focused on the development and commercialization of novel therapeutics based on its proprietary platforms of...
Jul 05, 2016 05:55 am UTC| Business
SOPHIA ANTIPOLIS, France, July 5, 2016 -- On July 4, 2016, Nicox S.A. (Nicox) and a company controlled by GHO Capital (the Partner) entered into a sale and purchase agreement pursuant to which the Partner undertook to...
DBV Technologies Proudly Welcomes Dr. Lucia Septien as Chief Medical Officer
Jul 05, 2016 05:35 am UTC| Business
MONTROUGE, France, July 5, 2016 -- DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage specialty biopharmaceutical company, today announced the appointment of Lucia Septin,...
Jul 05, 2016 05:34 am UTC| Business
Transaction values Nicox's European and International commercial operations and related late-stage development programs at up to €26 million Nicox to receive a €9 million upfront cash payment and a...
Victory Nickel Sells Non-Core Asset
Jul 04, 2016 20:19 pm UTC| Business
TORONTO , ON, July 4, 2016 -- Victory Nickel Inc. ("Victory Nickel" or the "Company") (CSE: NI, www.victorynickel.ca) today announced that it has sold its interest in a partnership (the "Partnership") created to trade in...
Britain may be leaving the EU, but English is going nowhere
Jul 04, 2016 19:36 pm UTC| Insights & Views Business
After Brexit, there are various things that some in the EU hope to see and hear less in the future. One is Nigel Farage. Another is the English language. In the early hours of June 24, as the referendum outcome was...